MATINAS BIOPHARMA HOLDINGS, INC.: 10-Q filed 2016-11-14

Name: MATINAS BIOPHARMA HOLDINGS, INC.: 10-Q filed 2016-11-14
Creator: MATINAS BIOPHARMA HOLDINGS, INC.

What MATINAS BIOPHARMA HOLDINGS, INC. reported in its quarterly report filed 2016-11-14 (fiscal Q3 2016): 29 published measures, 77 facts as tagged in accession 0001144204-16-134200.

This filing

Form: 10-Q (quarterly report)
Filed: 2016-11-14
Fiscal period: fiscal Q3 2016
Accession: 0001144204-16-134200 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All MATINAS BIOPHARMA HOLDINGS, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2016-09-30	11,306,760	USD
At 2015-12-31	8,406,078	USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

Period	Value	Unit	Days
At 2016-09-30	2,584,784	USD
At 2015-12-31	2,333,675	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit	Days
At 2016-09-30	8,721,976	USD
At 2015-12-31	6,072,403	USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

Period	Value	Unit
At 2016-09-30	6,219,641	USD
At 2015-12-31	3,226,997	USD
At 2015-09-30	4,362,758	USD
At 2014-12-31	2,590,713	USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Period	Value	Unit	Days
2016-07-01 to 2016-09-30	-1,838,436	USD	92
2016-01-01 to 2016-09-30	-5,706,931	USD	274
2015-01-01 to 2015-12-31	7,100,000	USD	365
2015-07-01 to 2015-09-30	-2,154,625	USD	92
2015-01-01 to 2015-09-30	-7,129,267	USD	273

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

Period	Value	Unit	Days
2016-01-01 to 2016-09-30	0	USD	274
2015-01-01 to 2015-09-30	53,247	USD	273

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

Period	Value	Unit	Days
2016-07-01 to 2016-09-30	0	USD	92
2016-01-01 to 2016-09-30	0	USD	274
2015-07-01 to 2015-09-30	59,858	USD	92
2015-01-01 to 2015-09-30	194,494	USD	273

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

Period	Value	Unit	Days
At 2016-09-30	-33,287,904	USD
At 2015-12-31	-23,187,164	USD

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

Period	Value	Unit	Days
At 2016-09-30	368,822	USD
At 2015-12-31	377,723	USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

Period	Value	Unit	Days
2016-01-01 to 2016-09-30	1,274,108	USD	274
2015-01-01 to 2015-09-30	1,165,550	USD	273

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

Period	Value	Unit	Days
2016-07-01 to 2016-09-30	-1,835,111	USD	92
2016-01-01 to 2016-09-30	-5,692,828	USD	274
2015-07-01 to 2015-09-30	-2,158,768	USD	92
2015-01-01 to 2015-09-30	-7,129,179	USD	273

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Period	Value	Unit	Days
At 2016-09-30	6,529,229	USD
At 2015-12-31	3,559,120	USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

Period	Value	Unit	Days
At 2016-09-30	1,360,639	USD
At 2015-12-31	1,128,534	USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

Period	Value	Unit	Days
At 2016-09-30	209,463	USD
At 2015-12-31	497,842	USD

Goodwill carrying amount

Recognized goodwill remaining after accumulated impairment. It arises from business combinations and does not measure the current value of the company’s brand.

Period	Value	Unit	Days
At 2016-09-30	1,336,488	USD
At 2015-12-31	1,336,488	USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

Period	Value	Unit	Days
2016-07-01 to 2016-09-30	1,835,111	USD	92
2016-01-01 to 2016-09-30	5,692,828	USD	274
2015-07-01 to 2015-09-30	2,218,626	USD	92
2015-01-01 to 2015-09-30	7,323,673	USD	273

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

Period	Value	Unit	Days
2016-07-01 to 2016-09-30	835,308	USD	92
2016-01-01 to 2016-09-30	2,399,595	USD	274
2015-07-01 to 2015-09-30	879,196	USD	92
2015-01-01 to 2015-09-30	3,682,336	USD	273

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

Period	Value	Unit	Days
At 2016-09-30	57,919,709	shares
At 2015-12-31	57,180,148	shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

Period	Value	Unit	Days
At 2016-09-30	35,917,737	USD
At 2015-12-31	29,253,848	USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

Period	Value	Unit	Days
At 2016-09-30	496,000	USD
At 2015-12-31	465,000	USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

Period	Value	Unit	Days
At 2016-09-30	127,000	USD
At 2015-12-31	87,000	USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

Period	Value	Unit	Days
At 2016-09-30	941,334	USD
At 2015-12-31	610,206	USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

Period	Value	Unit	Days
At 2016-09-30	254,005	USD
At 2015-12-31	231,797	USD

Net income available to common stockholders

Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.

Period	Value	Unit	Days
2016-07-01 to 2016-09-30	-6,232,245	USD	92
2016-01-01 to 2016-09-30	-10,100,740	USD	274
2015-07-01 to 2015-09-30	-2,154,625	USD	92
2015-01-01 to 2015-09-30	-7,129,267	USD	273

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

Period	Value	Unit	Days
2016-07-01 to 2016-09-30	999,803	USD	92
2016-01-01 to 2016-09-30	3,293,233	USD	274
2015-07-01 to 2015-09-30	1,339,430	USD	92
2015-01-01 to 2015-09-30	3,641,337	USD	273

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

Period	Value	Unit	Days
2016-01-01 to 2016-09-30	39,965	USD	274
2015-01-01 to 2015-09-30	32,658	USD	273

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

Period	Value	Unit	Days
2016-07-01 to 2016-09-30	-3,325	USD	92
2016-01-01 to 2016-09-30	-14,103	USD	274
2015-07-01 to 2015-09-30	4,143	USD	92
2015-01-01 to 2015-09-30	-88	USD	273

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

Period	Value	Unit	Days
2016-01-01 to 2016-09-30	0	USD	274
2015-01-01 to 2015-09-30	10,000,000	USD	273

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

Period	Value	Unit	Days
2016-01-01 to 2016-09-30	-288,379	USD	274
2015-01-01 to 2015-09-30	-289,471	USD	273

Inspect the source

Entity: MATINAS BIOPHARMA HOLDINGS, INC. / CIK 0001582554
Captured: 2026-09-20T09:22:54.236Z
SEC response SHA-256: 218993fbdcae524fc0c120e888a258d2be15df63a5b4cfc0f198760659dede1e

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001582554.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))